The project is co-financed by the European Union.
About the project:
INTERREG IPA-CBC HR-BA-ME182
Partners
Federal Ministry of Health of Bosnia and Herzegovina, Croatian Institute of Emergency Medicine and Ministry of Health of Montenegro
Total project value
EUR 865,767.09
Subsidy amount
EUR 735,902.03
Project implementation period
October 2017 - April 2020
Relevant links
http://www.interreg-hr-ba-me2014-2020.eu/
Short project description
The NeurNet project - Care management network for patients with pharmacoresistant epilepsy and patients with late stage Parkinson's disease started in October 2017, as part of cross-border cooperation INTERREG IPA-CBC HR-BA-ME182. The objective of the NeurNet project is to improve the quality and availability of services for patients with pharmacoresistant epilepsy and patients with late stage Parkinson's disease through the establishment of a network of reference centres and hospitals connected with modern ICT technologies that will maximize the capacity of the University Hospital Dubrava as the reference centre and the transfer of knowledge and good practice to the project beneficiary healthcare institutions in Croatia, Bosnia and Herzegovina and Montenegro. The total value of the project is EUR 865,767.09, and it is implemented in cooperation with the Federal Ministry of Health of Bosnia and Herzegovina as the lead partner and the Ministry of Health of Montenegro and the Croatian Institute of Emergency Medicine. The value of the Croatian component amounts to EUR 362,850.40, with each partner participating in co-financing with a total of 15 percent of own funds.
The healthcare institutions included in the project are the Split Clinical Hospital Centre, Zadar General Hospital, Dubrovnik General Hospital, General Hospital “Dr. Josip Benčević” Slavonski Brod and the General County Hospital in Vukovar and the Croatian Veterans Hospital in Croatia, the Croatian Hospital “Dr. fra. Mato Nikolić” Nova Bila, University Clinical Hospital Mostar and University Clinical Centre Tuzla in Bosnia and Herzegovina, and Clinical Centre of Montenegro and Hospital Bar in Montenegro. These institutions will be equipped with EEG devices, IT and video and audio communication equipment, which will enable accurate diagnosis, subsequent communication and medical data transfer between the hospital and the reference centre. The reference centre workers will thus obtain complete insight into the patient's condition without the need for patient transport and related complications. In cases where physical transportation of patients to the reference centre is required, patients will come with complete and accurate diagnosis, ready for treatment. This will ensure the maximum utilization and replication of the capacity and expertise of the University Hospital Dubrava throughout the programme area, thus increasing the quality and availability of services for patients with pharmacoresistant epilepsy and patients with late stage Parkinson's disease, while reducing their unnecessary transport, stress and health risks.
Indicators of successful implementation of the project are the establishment of an ICT network for the treatment of patients with pharmacoresistant epilepsy and patients with late stage Parkinson's disease, education and training for 30 neurologists throughout the programme area and 200 patients with pharmacoresistant epilepsy and patients with late stage Parkinson's disease who will be treated with new equipment and established network. The project duration is until 30 April 2020.
